Total Assets (Quarterly) Chart

View Total Assets (Quarterly) for DYAI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Assets (Quarterly) Chart
Start Trial

Historical Total Assets (Quarterly) Data

View and export this data back to 2004. Start Trial.
Date Value
June 30, 2026 6.536M
March 31, 2026 7.810M
December 31, 2025 9.946M
September 30, 2025 11.67M
June 30, 2025 8.138M
March 31, 2025 7.895M
December 31, 2024 9.930M
September 30, 2024 10.81M
June 30, 2024 10.63M
March 31, 2024 12.68M
December 31, 2023 8.219M
September 30, 2023 9.256M
June 30, 2023 11.07M
March 31, 2023 12.81M
December 31, 2022 13.71M
September 30, 2022 15.22M
June 30, 2022 17.22M
March 31, 2022 18.53M
December 31, 2021 21.30M
September 30, 2021 23.86M
June 30, 2021 26.45M
March 31, 2021 28.28M
December 31, 2020 30.07M
September 30, 2020 31.75M
June 30, 2020 33.73M
Date Value
March 31, 2020 35.39M
December 31, 2019 37.45M
September 30, 2019 38.52M
June 30, 2019 40.07M
March 31, 2019 41.86M
December 31, 2018 43.30M
September 30, 2018 43.75M
June 30, 2018 46.77M
March 31, 2018 48.82M
December 31, 2017 50.74M
September 30, 2017 52.86M
June 30, 2017 54.47M
March 31, 2017 55.67M
December 31, 2016 58.70M
September 30, 2016 63.85M
June 30, 2016 70.81M
March 31, 2016 70.50M
December 31, 2015 76.71M
September 30, 2015 12.82M
June 30, 2015 11.24M
March 31, 2015 10.75M
December 31, 2014 8.667M
September 30, 2014 10.39M
June 30, 2014 11.31M
March 31, 2014 13.74M

Total Assets Definition

Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.

Read full definition.

Total Assets (Quarterly) Range, Past 5 Years

View Total Assets (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Assets (Quarterly) Benchmarks

View Total Assets (Quarterly) Benchmarks
Start Trial
Agenus, Inc. 172.69M
Amgen, Inc. 95.64B
Anika Therapeutics, Inc. 183.47M
BioCryst Pharmaceuticals, Inc. 557.85M
Imunon, Inc. 14.99M

Total Assets (Quarterly) Related Metrics